Фатима А. Абдул Джаббар1, Раваа Аль-Чалаби1, Ахмед Ясин Аль-Тарбули1, Семаа А. Шабан2, Ахмед АбдулДжаббар Сулейман3
Альтернативный сплайсинг при аденокарциноме протоков поджелудочной железы приводит к нарушению регуляции иммунной системы
Математическая биология и биоинформатика. 2024;19(1):15-35.
doi: 10.17537/2024.19.15.
Список литературы
- Zhang L., Sanagapalli S., Stoita A. Challenges in diagnosis of pancreatic cancer. World J. Gastroenterol. 2018;24(19):2047–2060. doi: 10.3748/wjg.v24.i19.2047
- Rawla P., Sunkara T., Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J. Oncol. 2019;10(1):10–27. doi: 10.14740/wjon1166
- Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660
- Fukushima N., Zamboni G. Histologic Classification and Staging of Cystic Neoplasms. In: The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery. Third Edition. John Wiley & Sons, Ltd, 2018. P. 573–579. doi: 10.1002/9781119188421.ch74
- Diab M., Philip P.A. Uncommon Cancers of the Pancreas. In: Textbook of Uncommon Cancer. John Wiley & Sons, Ltd, 2017. P. 429–443. doi: 10.1002/9781119196235.ch29
- Rawla P., Sunkara T., Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J. Oncol. 2019;10(1):10–27. doi: 10.14740/wjon1166
- Collisson E.A., Bailey P., Chang D.K., Biankin A.V. Molecular subtypes of pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 2019;16(4):207–220. doi: 10.1038/s41575-019-0109-y
- Gao H.L., Wang W.Q., Yu X.J., Liu L. Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma. Exp. Hematol. Oncol. 2020;22(9):28. doi: 10.1186/s40164-020-00184-0
- Mostafa M.E., Erbarut-Seven I., Pehlivanoglu B., Adsay V. Pathologic classification of “pancreatic cancers”: current concepts and challenges. Chin. Clin. Oncol. 2018;6(6):59–59. doi: 10.21037/cco.2017.12.01
- Oldfield L.E., Connor A.A., Gallinger S. Molecular Events in the Natural History of Pancreatic Cancer. Trends Cancer. 2017;3(5):336–346. doi: 10.1016/j.trecan.2017.04.005
- Grimont A., Leach S.D., Chandwani R. Uncertain Beginnings: Acinar and Ductal Cell Plasticity in the Development of Pancreatic Cancer. Cell. Mol. Gastroenterol. Hepatol. 2022;13(2):369–382. doi: 10.1016/j.jcmgh.2021.07.014
- Deshwar A.B., Sugar E., Torto D., Jesus-Acosta A.D., Weiss M.J., Wolfgang C.L, Le D., He J., Burkhart R., Zheng L. et al. Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis. Ann. Pancreat. Cancer. 2018;1(2). doi: 10.21037/apc.2018.02.01
- Moffat G.T., Epstein A.S., O’Reilly E.M. Pancreatic cancer – A disease in need: Optimizing and integrating supportive care. Cancer. 2019;125(22):3927–3935. doi: 10.1002/cncr.32423
- Sahin I.H., Askan G., Hu Z.I., O’Reilly E.M. Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity? Ann. Oncol. 2017;28(12):2950–61. doi: 10.1093/annonc/mdx503
- Karamitopoulou E. Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features. Br. J. Cancer. 2019;121(1):5–14. doi: 10.1038/s41416-019-0479-5
- Riquelme E., Maitra A., McAllister F. Immunotherapy for Pancreatic Cancer: More than Just a Gut Feeling. Cancer Discov. 2018;8(4):386–388. doi: 10.1158/2159-8290.CD-18-0123
- Lu J., Wei S., Lou J., Yin S., Zhou L., Zhang W., Zheng S. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response. Med. Sci. Monit. 2020;26. doi: 10.12659/MSM.925733
- Zhang Y., Velez-Delgado A., Mathew E., Li D., Mendez F.M., Flannagan K., Rhim A.D., Simeone D.M., Beatty G.L., di Magliano M.P. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66(1):124–136. doi: 10.1136/gutjnl-2016-312078
- Chen B., Deng T., Deng L., Yu H., He B., Chen K., Zheng C., Wang D., Wang Y., Chen G. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma. BMC Cancer. 2021;21(1):1211. doi: 10.1186/s12885-021-08962-7
- Marzese D.M., Manughian-Peter A.O., Orozco J.I.J., Hoon D.S.B. Alternative splicing and cancer metastasis: prognostic and therapeutic applications. Clin. Exp. Metastasis. 2018;35(5):393–402. doi: 10.1007/s10585-018-9905-y
- Kawalerski R.R., Leach S.D., Escobar-Hoyos L.F. Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies. Oncotarget. 2021;12(6):525–533. doi: 10.18632/oncotarget.27901
- Venkat S., Alahmari A.A., Feigin M.E. Drivers of Gene Expression Dysregulation in Pancreatic Cancer. Trends Cancer. 2021;7(7):594–605. doi: 10.1016/j.trecan.2021.01.008
- Barrett T., Wilhite S.E., Ledoux P., Evangelista C., Kim I.F., Tomashevsky M., Marshall K.A., Phillippy K.H., Sherman P.M., Holko M., et al. NCBI GEO: archive for functional genomics data sets – update. Nucleic Acids Res. 2013;41(D1):D991–D995. doi: 10.1093/nar/gks1193
- Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Rudnev D., Evangelista C., Kim I.F., Soboleva A., Tomashevsky M., Marshall K.A., et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res. 2009;37(suppl_1):D885–D890. doi: 10.1093/nar/gkn764
- Brown J., Pirrung M., McCue L.A. FQC Dashboard: integrates FastQC results into a web-based, interactive, and extensible FASTQ quality control tool. Bioinformatics. 2017;33(19):3137–3139. doi: 10.1093/bioinformatics/btx373
- Chen S., Zhou Y., Chen Y., Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884–i890. doi: 10.1093/bioinformatics/bty560
- Tarasov A., Vilella A.J., Cuppen E., Nijman I.J., Prins P. Sambamba: fast processing of NGS alignment formats. Bioinformatics. 2015;31(12):2032–2034. doi: 10.1093/bioinformatics/btv098
- Pertea M., Pertea G.M., Antonescu C.M., Chang T.C., Mendell J.T., Salzberg S.L. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 2015;33(3):290–295. doi: 10.1038/nbt.3122
- Papatheodorou I., Moreno P., Manning J., Fuentes A.M.P., George N., Fexova S., Fonseca N.A., Füllgrabe A., Green M., Huang N., et al. Expression Atlas update: from tissues to single cells. Nucleic Acids Res. 2020;48(D1):D77–83. doi: 10.1093/nar/gkz947
- Tang Z., Kang B., Li C., Chen T., Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–560. doi: 10.1093/nar/gkz430
- Xie Z., Bailey A., Kuleshov M.V., Clarke D.J.B., Evangelista J.E., Jenkins S.L., Lachmann A., Wojciechowicz M.L., Kropiwnicki E., Jagodnik K.M., Jeon M., Ma'ayan A. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 2021;1(3):e90. doi: 10.1002/cpz1.90
- Ianevski A., Giri A.K., Aittokallio T. Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nat. Commun. 2022;13(1):1246. doi: 10.1038/s41467-022-28803-w
- Garcia-Moreno A., López-Domínguez R., Villatoro-García J.A., Ramirez-Mena A., Aparicio-Puerta E., Hackenberg M., Pascual-Montano A., Carmona-Saez P. Functional Enrichment Analysis of Regulatory Elements. Biomedicines. 2022;10(3):590. doi: 10.3390/biomedicines10030590
- Chen L., Chen K., Hong Y., Xing L., Zhang J., Zhang K., Zhang Z. The landscape of isoform switches in sepsis: a multicenter cohort study. Sci. Rep. 2022;12(1):10276. doi: 10.1038/s41598-022-14231-9
- Finotello F., Mayer C., Plattner C., Laschober G., Rieder D., Hackl H., Krogsdam A., Loncova Z., Posch W., Wilflingseder D. et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. bioRxiv. 2018. doi: 10.1101/223180
- Huang S., Song Z., Zhang T., He X., Huang K., Zhang Q., Shen J., Pan J. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas. Front. Immunol. 2020;11. doi: 10.3389/fimmu.2020.585034
- Sturm G., Finotello F., List M. Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data. In: Bioinformatics for Cancer Immunotherapy. Methods in Molecular Biology, vol 2120. Ed. Boegel S. New York, NY: Springer US; 2020. P. 223–332. doi: 10.1007/978-1-0716-0327-7_16
- Becht E., Giraldo N.A., Lacroix L., Buttard B., Elarouci N., Petitprez F., Selves J., Laurent-Puig P., Sautès-Fridman C., Fridman W.H., de Reyniès A. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218. doi: 10.1186/s13059-016-1070-5
- Le Large T.Y.S, Mantini G., Meijer L.L., Pham T.V., Funel N., van Grieken N.C.T., Kok B., Knol J., van Laarhoven H.W.M., Piersma S.R., et al. Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets. JCI Insight. 2020;5(15):e138290. doi: 10.1172/jci.insight.138290
- Hill W., Zaragkoulias A,. Salvador-Barbero B., Parfitt G.J., Alatsatianos M., Padilha A., Porazinski S., Woolley T.E., Morton J.P., Sansom O.J., Hogan C. EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas. Curr. Biol. 2021;31(12):2550–2560.e5. doi: 10.1016/j.cub.2021.03.094
- Iiizumi M., Hosokawa M., Takehara A., Chung S., Nakamura T., Katagiri T., Eguchi H., Ohigashi H., Ishikawa O., Nakamura Y., Nakagawa H. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth. Cancer Sci. 2006;97(11):1211–1216. doi: 10.1111/j.1349-7006.2006.00313.x
- Haouas H., Haouas S., Uzan G., Hafsia A. Identification of new markers discriminating between myeloid and lymphoid acute leukemia. Hematology. 2010;15(4):193–203. doi: 10.1179/102453310X12647083620769
- Iovanna J., Dusetti N. Speeding towards individualized treatment for pancreatic cancer by taking an alternative road. Cancer Lett. 2017;410:63–67. doi: 10.1016/j.canlet.2017.09.016
- Luo Y. The characteristic of stem-related genes with pancreatic carcinoma cell after irradiation. Heliyon. 2023;9(6):e17074. doi: 10.1016/j.heliyon.2023.e17074
- Yang H., Zhao L., Zhang Y., Li F.F. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma. Cancer Med. 2021;10(16):5696–5711. doi: 10.1002/cam4.4117
- Zalpoor H., Aziziyan F., Liaghat M., Bakhtiyari M., Akbari A., Nabi-Afjadi M., Forghaniesfidvajani R., Rezaei N. The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors. Cell Commun. Signal. 2022;20(1):186. doi: 10.1186/s12964-022-00951-y
- Sommariva M., Gagliano N. E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT. Cells. 2020;9(4):1040. doi: 10.3390/cells9041040
- Li H., Wu M., Zhao X. Role of chemokine systems in cancer and inflammatory diseases. MedComm. 2022;3(2):e147. doi: 10.1002/mco2.147
- Tan R., Nie M., Long W. The role of B cells in cancer development. Front. Oncol. 2022;12(958756). doi: 10.3389/fonc.2022.958756
- Dong Y., Wan Z., Gao X., Yang G., Liu L. Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies. Front. Immunol. 2021;12(609762). doi: 10.3389/fimmu.2021.609762
- Nagl L., Horvath L., Pircher A., Wolf D. Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives. Front. Cell Dev. Biol. 2020;8:766. doi: 10.3389/fcell.2020.00766
- Luo N. Editorial: Tumor microenvironment in cancer hallmarks and therapeutics. Front. Mol. Biosci. 2022;9:1019830. doi: 10.3389/fmolb.2022.1019830
- van der Leun A.M., Thommen D.S., Schumacher T.N. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer. 2020;20:218–232. doi: 10.1038/s41568-019-0235-4
- Li C., Jiang P., Wei S., Xu X., Wang J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol. Cancer. 2020;19(1):116. doi: 10.1186/s12943-020-01234-1
- Karakulak T., Moch H., von Mering C., Kahraman A. Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies. Front. Mol. Biosci. 2021;8. Article No. 726902. doi: 10.3389/fmolb.2021.726902
- Zhang Y., Weh K.M., Howard C.L., Riethoven J.J., Clarke J.L., Lagisetty K.H., Lin J., Reddy R.M., Chang A.C., Beer D.G. et al. Characterizing isoform switching events in esophageal adenocarcinoma. Mol. Ther – Nucleic Acids. 2022;29:749–768. doi: 10.1016/j.omtn.2022.08.018
- Vitting-Seerup K., Sandelin A. The Landscape of Isoform Switches in Human Cancers. Mol. Cancer Res. 2017;15(9):1206–1220. doi: 10.1158/1541-7786.MCR-16-0459
- Chen J., Weiss W.A. Alternative splicing in cancer: implications for biology and therapy. Oncogene. 2015;34(1):1–14. doi: 10.1038/onc.2013.570
- Potaczek D.P., Przytulska-Szczerbik A., Bazan-Socha S., Nastałek M., Wojas-Pelc A., Okumura K., Nishiyama C., Jurczyszyn A., Undas A., Wypasek E. Interaction between functional polymorphisms in FCER1A and TLR2 and the severity of atopic dermatitis. Hum. Immunol. 2020;81(12):709–713. doi: 10.1016/j.humimm.2020.08.002
- Wu H., Tian W., Tai X., Li X., Li Z., Shui J., Yu J., Wang Z., Zhu X. Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma. BMC Genomics. 2021;22(1):833. doi: 10.1186/s12864-021-08137-5
- Lin J., Wu Y.J., Liang X., Ji M., Ying H.M., Wang X.Y., Sun X., Shao C.H., Zhan L.X., Zhang Y. Network-based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancer. Mol. Carcinog. 2019;58(2):206–218. doi: 10.1002/mc.22920
|
|
|